PT  - JOURNAL ARTICLE
AU  - Ponce-de-Leon, Miguel
AU  - del Valle, Javier
AU  - Fernandez, José María
AU  - Bernardo, Marc
AU  - Cirillo, Davide
AU  - Sanchez-Valle, Jon
AU  - Smith, Matthew
AU  - Capella-Gutierrez, Salvador
AU  - Gullón, Tania
AU  - Valencia, Alfonso
TI  - COVID-19 Flow-Maps: An open geographic information system on COVID-19 and human mobility for Spain
AID  - 10.1101/2021.06.23.21259395
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.23.21259395
4099  - http://medrxiv.org/content/early/2021/07/02/2021.06.23.21259395.short
4100  - http://medrxiv.org/content/early/2021/07/02/2021.06.23.21259395.full
AB  - COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which has spread all over the world leading to a global pandemic. The fast progression of COVID-19 has been mainly related to the high contagion rate of the virus and the worldwide mobility of humans. In the absence of pharmacological therapies, governments from different countries have introduced several non-pharmaceutical interventions to reduce human mobility and social contact. Several studies based on Anonymised Mobile Phone Data have been published analysing the relationship between human mobility and the spread of coronavirus. However, to our knowledge, none of these data-sets integrates cross-referenced geo-localised data on human mobility and COVID-19 cases into one all-inclusive open resource. Herein we present COVID-19 Flow-Maps, a cross-referenced Geographic Information System that integrates regularly updated time-series accounting for population mobility and daily reports of COVID-19 cases in Spain at different scales of time spatial resolution. This integrated and up-to-date data-set can be used to analyse the human dynamics to guide and support the design of more effective non-pharmaceutical interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Generalitat de Catalunya through the project PDAD14/20/00001, and by the H2020 programme under Grant Agreement 825070 (INFORE) and the INB Grant (PT17/0009/0001 - ISCIII-SGEFI / ERDF).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Does not applyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data-sets are available at Zenodo and github. Links and DOIs are included in the main text https://github.com/bsc-flowmaps https://zenodo.org/record/4634662 https://zenodo.org/record/4634868 https://zenodo.org/record/4634895 https://zenodo.org/record/4635258